Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse - Concepedia

Concepedia

Publication | Closed Access

Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

757

Citations

33

References

1999

Year

W.K. Alfred Yung, Michael D. Prados, Ricardo Yayá, Steven S. Rosenfeld, Michael Brada, Henry S. Friedman, Robert E. Albright, Jeffrey J. Olson, Susan M. Chang, Alison M. O'Neill,

Journal of Clinical Oncology

Abstract

Temozolomide demonstrated good single-agent activity, an acceptable safety profile, and documented HQL benefits in patients with recurrent AA.

References

	Year	Citations

Page 1